ENTBF (Entheon Biomedical) Total Stockholders Equity: $0.35 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Entheon Biomedical Total Stockholders Equity?

Entheon Biomedical ENTBF Total Stockholders Equity is $0.35 Mil as of May. 2026.

Entheon Biomedical's Total Stockholders Equity for the quarter that ended in May. 2026 was $0.35 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Entheon Biomedical's Book Value per Share for the quarter that ended in May. 2026 was $0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Entheon Biomedical's Debt-to-Equity for the quarter that ended in May. 2026 was 0.00.

Entheon Biomedical  (OTCPK:ENTBF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Entheon Biomedical's Book Value per Share for the quarter that ended in May. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.35-0)/13.859
=0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Entheon Biomedical's Debt-to-Equity for the quarter that ended in May. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0.35
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Total Stockholders Equity Related Terms

Entheon Biomedical Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Total Stockholders Equity Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 7.20 0.46 0.23 0.10 0.23

Entheon Biomedical Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.28 0.23 0.16 0.35
What does a Total Stockholders Equity of $0.35 Mil mean?
Entheon Biomedical (ENTBF) has a Total Stockholders Equity of $0.35 Mil as of May. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Entheon Biomedical and its competitors.
Is Entheon Biomedical's Total Stockholders Equity too high?
Entheon Biomedical's current Total Stockholders Equity is $0.35 Mil.
How does Entheon Biomedical's Total Stockholders Equity compare to VRTX and REGN?
Entheon Biomedical's Total Stockholders Equity of $0.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Entheon Biomedical and its competitors. Entheon Biomedical's current Total Stockholders Equity is $0.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Total Stockholders Equity of $0.35 Mil. The current Total Stockholders Equity is $0.35 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Total Stockholders Equity is $0.35 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.